Delivery Order SPE2DB22D2206-SPE2DB26FDR72
- Not listed
- The Defense Logistics Agency awarded a $3,677.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for supply of Mounjaro 15 mg/0.5 mL pens on September 3, 2025, with completion by September 4, 2025. This non-set-aside competitively awarded contract represents a single delivery order fulfillment from AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $7,755.60 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pens on August 7, 2025, with completion targeted for August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,454.04 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical supply will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a non-set-aside procurement, this award reflects open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens valued at $5,564.41. This delivery order, issued under a firm fixed-price contract with no set-aside designation, is due for completion by July 14, 2025. AmerisourceBergen will fulfill this order from its corporate office in Conshohocken, Pennsylvania, where the company maintains operations as a primary pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens valued at $1,904.63 with a completion date of June 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,338.88 on April 25, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This is a firm fixed-price contract with an ultimate completion date of April 28, 2025, and represents a competitive award with no set-aside designation. The contract is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens with a ceiling value of $26,411.84. This firm fixed price delivery order represents a non-competitive award and is scheduled for completion by September 29, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters as a major pharmaceutical...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,812.90 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on April 22, 2025, with completion scheduled for April 23, 2025. This competitively awarded, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under a child delivery order structure, leveraging the company's broader contracting...
- The Defense Logistics Agency awarded a $11,046.77 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens on September 3, 2025, with completion scheduled for September 4, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $1,360.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This contract was awarded competitively with no set-aside designation and has an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under a larger procurement vehicle...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDR72Delivery Order
The Defense Logistics Agency awarded a $3,265.08 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. The award was made without set-aside designation through open competition, with an ultimate completion date of October 21, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in delivering a diverse range of pharmaceutical products, from specialty medications to generic drugs, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contracting arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 10/20/25 |